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Abstract
Disruption of the polyubiquitin gene Ubc leads to a defect in fetal liver development, which can be partially rescued by
increasing the amount of ubiquitin. However, it is still not known why Ubc is required for fetal liver development and the
nature of the defective cell types responsible for embryonic lethality have not been characterized. In this study, we assessed
the cause of embryonic lethality with respect to the fetal liver hematopoietic system. We found that Ubc was highly
expressed in the embryonic liver, and the proliferation capacity of fetal liver cells was reduced in Ubc
2/2 embryos.
Specifically, Ubc was most highly expressed in hematopoietic cells, and the proliferation capacity of hematopoietic cells was
significantly impaired in Ubc
2/2 embryos. While hematopoietic cell and hematopoietic stem cell (HSC) frequency was
maintained in Ubc
2/2 embryos, the absolute number of these cells was diminished because of reduced total liver cell
number in Ubc
2/2 embryos. Transplantations of fetal liver cells into lethally irradiated recipient mice by non-competitive
and competitive reconstitution methods indicated that disruption of Ubc does not significantly impair the intrinsic function
of fetal liver HSCs. These findings suggest that disruption of Ubc reduces the absolute number of HSCs in embryonic livers,
but has no significant effect on the autonomous function of HSCs. Thus, the lethality of Ubc
2/2 embryos is not the result of
intrinsic HSC failure.
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Introduction
Ubiquitin (Ub) is a small, highly conserved eukaryotic protein
that plays a crucial role in diverse cellular signaling pathways,
including targeting proteins for proteasomal degradation [1,2,3].
Inside cells, Ub exists in a dynamic equilibrium between free Ub
and monomeric/polymeric Ub-substrate conjugate pools [4,5].
The Ub conjugation reaction is mediated by a series of enzymes
E1-E3, and the deconjugation reaction is mediated by isopepti-
dases or deubiquitylating enzymes, during which most Ub is
recycled back to the free Ub pool [6,7]. It is believed that
maintaining cellular steady-state Ub levels is important for their
function and survival [8,9,10]. Although Ub is a unique protein, it
is encoded by two different classes of ubiquitin genes; constitutively
expressed monomeric Ub ribosomal fusion genes and stress-
regulated polyubiquitin genes [11,12]. Under stress or even
normal conditions, the contribution of polyubiquitin genes
towards total cellular Ub levels is very significant [13,14].
In mammals, there are two polyubiquitin genes, Ubb and Ubc,
and disruptions of these genes in mice have been shown to exhibit
variousphenotypes[13,14,15,16,17].DisruptionofUbbreducedUb
levels in the gonads and hypothalamus, which resulted in infertility,
hypothalamic neurodegeneration, metabolic abnormalities, and
impaired energy and sleep homeostasis [14,15,16,17]. On the other
hand, disruption of Ubc resulted in embryonic lethality with
defective fetal liver development [13]. Although ectopic expression
of Ub partially rescued the Ubc
2/2 phenotypes by delaying the
onset of lethality, the precise mechanism underlying the cause of
Ubc
2/2 embryonic lethality is still unknown.
In a study that used mouse embryonic fibroblasts (MEFs) isolated
from Ubc
2/2 embryos, the phenotypes of Ubc
2/2 MEFs including
reduced proliferation and delayed cell-cycle progression were found
to be completely rescued by increasing cellular Ub levels [13].
However, under stress conditions, ectopic expression of Ub was not
sufficienttoincrease the cellularUblevelsobserved inwild type cells
under stress, resulting in the failure of rescuing the phenotypes of
Ubc
2/2 MEFs. Therefore, the phenotypes of Ubc
2/2 MEFs are a
direct consequence of reduced cellular Ub levels. In addition, we
previously showed that the contribution of Ubc toward total Ub
levels is highest in liver among all other tissues investigated in adult
mice [13]; therefore, it is highly likely that the defective fetal liver
development is closely related to the reduced cellular Ub levels in
Ubc
2/2 embryonic liver.
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32956Here, as was observed in Ubc
2/2 MEFs, we found that fetal
liver cells exhibit reduced proliferation, presumably due to the
reduced cellular Ub levels in fetal liver. Rapid enlargement of the
fetal liver during the midgestation period is important because the
fetal liver becomes the primary site of hematopoiesis at embryonic
days (E) 11–11.5, during which hematopoietic stem cells (HSCs)
seed the liver from the aorta-gonad mesenepheros (AGM) region
[18]. Through hematopoiesis, all the blood cell types are generated
including myeloid and lymphoid lineages [19], therefore it is an
essential process for survival. It has also been known that the
cycling status of fetal liver HSCs is higher than that in adult bone
marrow (BM) stem cells, which are largely quiescent [20].
However, here we demonstrate by non-competitive and compet-
itive reconstitution methods that cell autonomous hematopoietic
function in the Ubc
2/2 embryonic liver is essentially intact. These
findings show that Ubc
2/2 embryonic lethality is not directly
caused by the impaired function of HSCs themselves, but rather
by autonomous insufficiency in Ubc
2/2 liver function to support
hematopoiesis.
Results
Reduced proliferation and increased apoptosis in Ubc
2/2
fetal liver cells
We have previously demonstrated that targeted disruption of
polyubiquitin gene Ubc leads to embryonic lethality between
embryonic days (E) 12.5 and 14.5, which is most likely due to the
defect in fetal liver development [13]. Although we were able to
partially rescue the lethal phenotype of Ubc
2/2 embryos by
ectopic expression of Ub, the exact cause of embryonic lethality is
still unknown. At stages E11–11.5, the size of the liver rapidly
increases because it becomes the principal source of hematopoietic
activity. This suggests that fetal liver cells need to undergo rapid
proliferation during the midgestation period to reach a dense and
homogenous architecture at E13.5. In fact, we have shown that
the size of the fetal liver is smaller in Ubc
2/2 embryos when
compared to wild type (Ubc
+/+) at E13.5 [13]. To determine
whether the reduced size of Ubc
2/2 fetal liver was due to the
reduced proliferation of fetal liver cells, sagittal liver sections from
E12.5 and E13.5 embryos were generated and stained with a
proliferation marker, Ki-67 or phospho-histone 3 (PH3)
(Figure 1A). As expected, we observed a marked reduction in
the proliferation of Ubc
2/2 fetal liver cells, which was demon-
strated using two different proliferation markers (Ki-67 and PH3).
In addition, not only was reduced cellularity apparent, but also an
altered liver architecture with dissociated parenchymal cells were
observed in Ubc
2/2 fetal liver (Figure 1A, upper panel). Therefore,
to determine whether apoptosis increased in Ubc
2/2 fetal liver,
liver sections from E12.5 and E13.5 embryos were analyzed using
the TUNEL assay (Figure 1B). Although TUNEL-positive cells
were rare in wild-type or Ubc
+/2 liver sections, positive cells were
observed focally in Ubc
2/2 liver sections, especially where the liver
structure was altered.
To identify the cell types that were affected in proliferation and
apoptosis due to deletion of Ubc, we then processed fetal liver cells
from E13.5 embryos to prepare cytospin slides attached with equal
number of fetal liver cells. We stained fetal liver cells with CD45
(pan-hematopoietic marker), E-cadherin (epithelial cell marker),
AFP (hepatocyte marker), and Ter119 (erythroid cell marker) in
combination with a proliferation marker (Figure 1C) or with an
apoptotic cell detection using the TUNEL assay (Figure 1D). We
found that the number of CD45, E-cadherin, AFP, and Ter119-
positive cells were not largely distinguishable between Ubc
+/2 and
Ubc
2/2 fetal liver cells. Based on our data, all cell types that we
investigated exhibited reduced proliferation in Ubc
2/2 embryonic
livers (Figure 1C). Intriguingly, we found that Ter119-positive
Ubc
2/2 fetal liver cells were more apoptotic than any other cell
types that we investigated (Figure 1D). Taken together, it seems
that, due to deletion of Ubc, all cell types were affected in
proliferation and Ter119-positive cells were affected most in
apoptosis. Therefore, Ubc may be necessary for fetal liver cell
proliferation and may protect cells from undergoing apoptosis.
These results may suggest that Ubc expression is required in an
attempt to increase cellular Ub levels in these apoptotic cells. It is
also possible that Ubc may be upregulated as a stress response in
apoptotic cells, although we cannot exclude the possibility that Ub
deficiency in a Ubc
2/2 background may lead to cellular apoptosis.
Ub protein and Ubc expression levels are high in fetal
liver
To investigate how cellular Ub levels in the fetal liver are
affected during embryonic development, we determined total Ub
levels in whole embryos and embryonic livers by indirect
competitive ELISA, in which all forms of Ub was converted to
monomeric Ub using a Ub-specific protease (Usp2-cc) and the
monomeric Ub was quantified (Figure 2A, left panel) [21]. We
found that total Ub levels in both whole embryos and embryonic
livers were well maintained throughout the midgestation period
from E11.5 to E13.5, with significantly higher Ub levels in
embryonic livers. However, a loss of Ubc reduced total Ub levels by
approximately 40% in E12.5 embryonic liver (Figure 2A, right
panel). In accordance with cellular Ub levels during embryonic
development, Ubc mRNA levels, which were determined by
quantitative real-time RT-PCR, did not change significantly
during the midgestation period (data not shown). Although it
was expected that the other polyubiquitin gene Ubb would be
upregulated to compensate for the loss of Ubc in Ubc
2/2 fetal liver,
because of the lower levels of Ubb than Ubc in fetal liver as well as
the fact that the Ub-coding potential of Ubb was about half that of
Ubc (9 Ubs per Ubc transcript vs. 4 Ubs per Ubb transcript), it seems
that its contribution to increase the total Ub levels was quite
minimal (Figure 2B). In accordance with high Ub levels in
embryonic livers, the spatial distribution of Ubc expression in Ubc
+/
2 embryos, which was determined by direct visualization of GFP
fluorescence from a GFP-puro
r fusion protein knocked in to the
Ubc locus, clearly indicated that Ubc was highly expressed in the
embryonic liver (Figure 2C, indicated by an arrow). In contrast,
Ubb was not expressed at high levels in the Ubb
+/2 embryonic
liver, and was comparable to other tissues (Figure 2C, indicated by
an arrow), although both Ubb and Ubc were highly expressed in the
embryonic heart (Figure 2C, indicated by arrowheads). Therefore,
given the fact that the contribution of Ubc to the total Ub levels in
liver was relatively higher than in other tissues [13], high Ubc
expression in the embryonic liver seems to be responsible for the
high Ub levels in the embryonic liver.
Ubc expression levels are high in hematopoietic cells and
their proliferation capacity is impaired in Ubc
2/2 fetal
liver
To identify the cell types that exhibit high Ubc expression and
the cell types that show altered proliferation capacity upon
deletion of Ubc, we processed fetal liver cells, stained with CD45
and Ter119, and analyzed by flow cytometry. We were able to
identify CD45-positive cells in both Ubc
+/2 and Ubc
2/2 fetal liver
cells, which were present at similar frequencies of about 7%
(Figure 3C). Similarly, we found that fetal liver-derived progenitor
cell frequency was about 2% in both Ubc
+/2 and Ubc
2/2 fetal liver
Ubc Disruption in Fetal Liver Hematopoietic System
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e32956Figure 1. Reduced proliferation and increased apoptosis in Ubc
2/2 fetal liver cells. (A) (Upper panel) Paraffin-embedded liver sections were
prepared from wild-type (Ubc
+/+) and Ubc
2/2 embryos at E13.5 and stained with the proliferation marker, Ki-67. (Lower panel) Frozen liver sections
were prepared from Ubc
+/2 and Ubc
2/2 embryos at E12.5 and stained with the proliferation/mitotic marker, PH3 (red), and DNA was visualized using
TO-PRO-3 iodide (blue). Ubc
+/2 embryos also served as controls because they had no phenotypic difference relative to wild-type embryos. (B) (Upper
panel) TUNEL assay of paraffin-embedded E13.5 embryonic liver sections. TUNEL-positive cells were rare in Ubc
+/+ embryonic liver sections, but were
observed focally in Ubc
2/2 embryonic liver sections. (Lower panel) TUNEL assay of frozen E12.5 embryonic liver sections (red), with DNA visualization
using TO-PRO-3 iodide (blue). (C). Cytospin slides were prepared from Ubc
+/2 and Ubc
2/2 embryos at E13.5 and stained with CD45 (pan-
hematopoietic marker), E-cadherin (epithelial cell marker), AFP (hepatocyte marker), and Ter119 (erythroid cell marker) in combination with a
proliferation marker (PH3 or Ki-67) and DNA was visualized with DAPI. Examples of proliferating cells that were also positive for cell-type specific
markers were indicated by arrowheads. (D) Fetal liver cells on cytospin slides were subjected to the double-labeling fluorescence TUNEL assay with
appropriate markers. Examples of apoptotic cells that were also positive for cell-type specific markers were indicated by arrowheads. All data are
representative images from three different embryos per genotype. Scale bars, 50 mm (upper panels in (A/B) and all panels in (C/D)); 200 mm (lower
panels in (A/B)).
doi:10.1371/journal.pone.0032956.g001
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by about 60% in the Ubc
2/2 fetal liver relative to Ubc
+/2 fetal liver
(Figure 3A), these results indicate the concomitant reduction in the
absolute number of hematopoietic cells and HSCs/progenitor cells
in the Ubc
2/2 fetal liver. Ter119-positive cells were most abundant
in both Ubc
+/2 and Ubc
2/2 fetal liver cells, although its frequency
was reduced by about 10% in Ubc
2/2 fetal liver cells (Figure 3C).
We then monitored GFP fluorescence of these cell populations in
Ubc
+/2 fetal liver cells, and found that CD45-positive cells
exhibited the highest GFP fluorescence, suggesting that Ubc
expression levels in hematopoietic cells were much higher than any
other cell types (Figures 3D and 3F). We also demonstrated that
CD45-positive cells were highly proliferating and the percentages
of Ki-67-positive proliferating cells were significantly reduced in
Ubc
2/2 fetal liver cells regardless of the cell types (Figures 3E and
3G), which is consistent with the immunostaining results (see
Figure 1C). Therefore, our data suggest that CD45-positive
hematopoietic cells have the highest Ubc transcriptional activity
and proliferation capacity in E13.5 embryonic liver, and there is a
correlation between Ubc transcriptional activity and proliferation
capacity among different cell types.
The capacity of hematopoiesis in Ubc
2/2 fetal liver cells
was only slightly affected under competitive
microenvironment
At the midgestation period, HSCs migrate from the AGM into
the liver, and the liver becomes the major site of hematopoiesis
[18]. During this period, fetal liver cells proliferate extensively. We
hypothesized that the reduced proliferation capacity in Ubc
2/2
fetal liver may hamper the function of HSC to support
hematopoiesis, which can be detrimental to embryonic develop-
ment. Therefore, we decided to examine whether impaired HSC
function could be a cause for Ubc
2/2 embryonic lethality. In order
to test whether the abnormality in the Ubc
2/2 fetal liver results in
cell autonomous defects in HSC function, we assayed the
progenitor/HSC activity using the non-competitive and compet-
itive reconstitution method. For non-competitive reconstitution,
1610
6 whole fetal liver cells obtained from E13.5 embryos were
transplanted into lethally irradiated mice (Figure 4A). For
competitive reconstitution, 1.5610
5 fetal liver cells were trans-
planted together with 2610
5 congenic recipient-type bone marrow
cells (Figure 4B). At 4, 8, 12, and 16 week after transplantation,
Figure 2. Increased Ub protein and Ubc expression levels in fetal liver. (A) (Left panel) Total Ub levels in whole embryos and embryonic livers
during midgestation period from E11.5 to E13.5. Tissue lysates from wild-type embryos (n=3) or embryonic livers (n=3) at different embryonic days
were treated with Usp2-cc and subjected to indirect competitive ELISA. (Right panel) Total Ub levels in Ubc
+/+ and Ubc
2/2 embryonic livers (n=3
each) at E12.5. Ub levels in Ubc
2/2 embryonic livers were significantly reduced (by about 40%). (B) Ubc and Ubb mRNA levels in Ubc
+/+ and Ubc
2/2
embryonic livers (n=3 each) at E12.5. Total RNA was isolated from embryonic livers and Ubc and Ubb mRNA levels were measured by quantitative
real-time RT-PCR and normalized to 18S rRNA levels. No Ubc mRNA was detected in Ubc
2/2 embryonic livers and slight compensation by Ubb mRNA
in Ubc
2/2 embryonic livers was observed. (C) High Ubc, but not Ubb, expression in embryonic livers. Ubc and Ubb expression in embryos at E12.5 was
monitored by direct visualization of GFP fluorescence in Ubc
+/2 and Ubb
+/2 embryos, respectively. Arrows indicate embryonic livers and arrowheads
indicate embryonic hearts, in which both Ubc and Ubb are highly expressed. All data are expressed as the means 6 SEM from the indicated number
of samples.
#P,0.1;
*P,0.05;
***P,0.001 vs. Ub levels in whole embryos (A) or wild-type (Ubc
+/+) embryonic livers (B). Scale bar, 1 mm.
doi:10.1371/journal.pone.0032956.g002
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PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e32956Figure 3. Increased Ubc expression and proliferation capacity in hematopoietic cells. (A) The number of total liver cells from Ubc
+/2
(n=38) and Ubc
2/2 embryos (n=13) at E13.5 was measured using a hematocytometer. (B) Fetal liver cells from Ubc
+/2 embryos at E13.5 were stained
with CD45 and Ter119, and analyzed by flow cytometry. CD45
+, Ter119
+, and CD45
2/Ter119
2 cells were defined as P1, P2, and P3 populations,
respectively. (C) The percentage of P1, P2, and P3 populations in E13.5 Ubc
+/+, Ubc
+/2, and Ubc
2/2 fetal liver cells (n=3 each) are shown. (D)
Representative histograms for GFP fluorescence of P1, P2, and P3 populations in E13.5 Ubc
+/+ and Ubc
+/2 fetal liver cells. Ubc
+/+ cells served as
background fluorescence controls because they were lack of GFP. (E) Representative histograms for Ki-67 immunoreactivity of P1, P2, and P3
populations in E13.5 Ubc
+/2 and Ubc
2/2 fetal liver cells. Ki-67 immunoreactivity was indirectly monitored by Alexa Fluor 488-conjugated anti-mouse
IgG (AF488). Cells within the M1 marker area were considered as Ki-67-positive. (F) Mean GFP fluorescence of P1, P2, and P3 populations in E13.5
Ubc
+/+ and Ubc
+/2 fetal liver cells (n=3 each). (G) The percentage of Ki-67-positive cells of P1, P2, and P3 populations in E13.5 Ubc
+/2 and Ubc
2/2 fetal
liver cells (n=3 each). All data in (A), (C), (F), and (G) are expressed as the means 6 SEM from the indicated number of samples. In (A), open circles
represent data from an individual sample and horizontal solid bars represent the means from the indicated number of samples.
*P,0.05;
**P,0.01;
***P,0.001 vs. control (Ubc
+/+ or Ubc
+/2) embryos unless otherwise indicated by horizontal bars.
doi:10.1371/journal.pone.0032956.g003
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examine the contribution of donor cells to lymphoid (T cells and B
cells) and myeloid lineages (data not shown for 8 and 12 weeks). In
both competitive and non-competitive settings, loss of Ubc had
only a modest impact on HSC function both in terms of
repopulation kinetics and total reconstitution of B cell, T cell,
and myeloid lineages (Figures 4A and 4B). However, the long-term
contribution to myeloid lineages was significantly diminished in
the Ubc
2/2 competitive transplants at 16 weeks after transplan-
tation.
To explore this further, we monitored donor-marked granulo-
cyte reconstitution, which, because of their short life span
(approximately 4–6 days) in contrast to T cells and B cells, has
been used as a measure of an on-going HSC activity [22,23].
Therefore, continued stem cell activity is required to keep
generating granulocytes. Both granulocyte frequencies
(Figure 4C, left panel) and granulocyte chimerism (Figure 4C,
right panel) were diminished in the absence of Ubc, suggesting
subtle autonomous defects in Ubc
2/2 HSCs. However, because
the overall reconstitution of Ubc
2/2 HSCs was generally
comparable to control cells, we can conclude that the Ubc
2/2
embryonic lethality may not be directly caused by cell autonomous
failure in HSCs, although we cannot exclude the possibility that
the reduced number of HSCs may play a role in embryonic
lethality.
Discussion
Disruption of the polyubiquitin gene Ubc leads to a defect in
fetal liver development, which can be partially rescued by
increasing the amount of ubiquitin (Ub) [13]. However, it is still
not known why Ubc is required for fetal liver development and the
nature of defective cell types that are responsible for the lethality in
Ubc
2/2 embryos have not yet been characterized. At embryonic
days (E) 11–11.5, right before the onset of Ubc
2/2 embryonic
lethality, hematopoietic stem cells (HSCs) migrate into the liver,
which rapidly enlarges and becomes the principal site of
hematopoietic activity [18]. Therefore, it is possible that the cause
of Ubc
2/2 embryonic lethality may be due to the failure in the
fetal liver hematopoietic system.
In this study, we tried to identify the cell-type specific role of Ubc
in fetal liver development, which cannot be compensated for by
other ubiquitin genes. To this end, we first monitored the
proliferation capacity in Ubc
2/2 fetal liver cells and found that it
was significantly reduced and associated with increased apoptosis.
Specifically, we found that Ubc was most highly expressed in
hematopoietic cells, and the proliferation capacity of hematopoi-
etic cells was significantly impaired in Ubc
2/2 embryos. Based on
flow cytometric analysis, Ubc transcriptional activity seemed to
correlate well with the proliferation status of the cells (see
Figures 3F and 3G). These results suggest that upregulation of
Ubc to maintain enough Ub pools may be required for cell
proliferation. Therefore, cells with high Ubc transcriptional activity
are highly proliferative with enough Ub pools. However, it is also
possible that cells with high Ubc transcriptional activity are simply
under stress regardless of their proliferation status or cell types.
All of the polyubiquitin gene knockout phenotypes seem to be
related to cell-type specific reduction of Ub levels. For example,
since Ubc was highly expressed in MEFs, Ub levels were reduced
by ,40% in Ubc
2/2 MEFs [13]. We demonstrated that reduced
proliferation, premature senescence, and abnormal cell cycle
progression in Ubc
2/2 MEFs were completely rescued by
increasing the Ub levels up to wild-type levels [13]. Since Ubb is
highly expressed in germ cells, Ub levels were dramatically
reduced by ,70% in adult Ubb
2/2 testes, which is mostly
comprised of germ cells [14]. Interestingly, although Ub levels
were not significantly reduced in Ubb
2/2 ovaries, they were
reduced by ,70% in isolated oocytes from Ubb
2/2 mice,
suggesting that the effect on total Ub levels due to disruption of
polyubiquitin gene depends highly on the contribution of the
polyubiquitin gene to the total Ub pools, which varies based on
cell types [14]. Hypothalamic phenotypes in Ubb
2/2 mice also
seemed to be closely related to the reduced Ub levels in the
hypothalamus by ,30%, but not in the whole brain [15].
Therefore, reduced proliferation of Ubc
2/2 fetal liver cells is likely
caused by the Ub deficiency in the Ubc
2/2 embryonic liver, in
which Ub levels were reduced by ,40%. Currently, it is not clear
which cell types in the embryonic liver are affected most due to
deletion of Ubc, although we speculate that hematopoietic cells
may be affected most, simply based on their high Ubc expression
levels. This type of analysis would require the isolation of specific
cell types and determination of Ub levels therein.
Interestingly, whereas the frequency of primitive HSCs and
hematopoietic cells were maintained (about 2% and 7% of total
liver cells, respectively), the reduced cellularity of the Ubc
2/2 fetal
livers lead to a reduction in the absolute number of HSCs and
hematopoietic cells. We next assessed the cause of Ubc
2/2
embryonic lethality with respect to the failure in the fetal liver
hematopoietic system. To investigate whether the hematopoietic
defect is caused by the loss of Ubc during embryonic development,
we transplanted whole fetal liver cells from wild-type and Ubc
2/2
E13.5 embryos into lethally irradiated recipient mice by non-
competitive and competitive transplantation, and performed
peripheral blood analysis to measure donor contribution to
hematopoietic lineages at 4, 8, 12, and 16 weeks after
transplantation. Under non-competitive conditions, the donor
contribution to lymphoid and myeloid lineages was not signifi-
cantly different between the two genotypes, suggesting that the
hematopoietic function of Ubc
2/2 fetal liver remained intact.
However, under competitive conditions, Ubc
2/2 fetal liver
exhibited a marginal yet significantly reduced capacity to
reconstitute hematopoietic function. Therefore, these combined
results suggest that although the hematopoietic system in Ubc
2/2
embryos is slightly impaired, the embryonic lethality of Ubc
2/2
mice is not likely caused by an autonomous failure of the
hematopoietic system.
Although Ubc
2/2 embryonic lethality may be caused by the
reduced number of HSCs and hematopoietic cells with impaired
proliferation capacity, our data also suggest that defects in
erythroid cell development may also contribute to the Ubc
2/2
embryonic lethality. Although Ubc expression levels in Ter119-
positive cells were not as high as CD45-positive cells (see
Figure 3F), many Ter119-positive cells were apoptotic and the
proliferation capacity of Ter119-positive cells was also significantly
impaired in Ubc
2/2 fetal liver (see Figure 3G). These were
reflected in the reduced frequency of Ter119-positive cells in
Ubc
2/2 fetal liver cells (see Figure 3C). In addition, as shown in
our previous report [13], the color of Ubc
2/2 fetal liver was very
pale and the close examination of fetal liver histology revealed the
reduced number of mature enucleated red blood cells, which were
stained intensely red with H&E, in Ubc
2/2 fetal liver. Taken
together, it is also possible that Ubc
2/2 embryonic lethality could
be caused, at least in part, by defects in erythroid cell development,
possibly resulting in anemia. Further detailed analysis will prove
the cell autonomous and non-cell autonomous role of Ubc in
erythroid cell development.
In conclusion, Ubc
2/2 embryonic lethality does not seem to be
due to intrinsic failure of the hematopoietic system, but rather may
Ubc Disruption in Fetal Liver Hematopoietic System
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e32956Figure 4. Only slightly reduced progenitor and HSC function in Ubc
2/2 fetal liver cells under competitive microenvironment. (A) For
non-competitive reconstitution, lethally irradiated recipient mice were transplanted with whole fetal liver cells from E13.5 Ubc
+/+ and Ubc
2/2 embryos
(n=3 each). For each genotype, whole fetal liver cells from one embryo were used for transplantation into 3 recipient mice. (B) For competitive
reconstitution, lethally irradiated recipient mice were transplanted with whole fetal liver cells from E13.5 Ubc
+/+ (n=10) and Ubc
2/2 embryos (n=7)
together with recipient-type whole BM cells. Whole fetal liver cells from three different Ubc
+/+ embryos were used for transplantation into 13 recipient
mice (3–5 recipient mice/embryo), but 3 out of 13 were not graphed because they were not multilineage engrafted. Similarly, whole fetal liver cells
from three different Ubc
2/2 embryos were used for transplantation into 14 recipient mice (4–5 recipient mice/embryo), but 7 out of 14 were not
graphed because they were not multilineage engrafted. In both reconstitution experiments, contributions of donor-marked progenitor/HSCs to
lymphoid (B cells, T cells) and myeloid lineages were analyzed using peripheral blood drawn at 4 and 16 weeks after transplantation. (C) (Left panel)
Donor-marked granulocyte frequency was expressed as % of white blood cells (%WBC) at 4-week intervals after transplantation of whole fetal liver
cells from E13.5 Ubc
+/+ (n=11) and Ubc
2/2 embryos (n=7) into recipient mice in a competitive manner. (Right panel) Donor granulocyte chimerism
Ubc Disruption in Fetal Liver Hematopoietic System
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e32956be due to the reduced number of HSCs. It is also possible that
Ubc
2/2 embryonic lethality could, at least in part, be due to
defects in the proliferation and/or differentiation capacity of fetal
liver epithelial cells such as hepatocytes and ductal cells. Further
investigation using these cell types is required to directly prove the
role of Ub in fetal liver development and eventually identify the
underlying molecular mechanisms for the embryonic lethality of
Ubc
2/2 fetal liver.
Materials and Methods
Mouse studies
All mice were maintained in plastic cages with ad libitum access
to food and water. All animal procedures followed National
Institute of Health guidelines with the approval of Stanford
University Administrative Panel on Laboratory Animal Care
(APLAC; #13745) and the University of Seoul Institutional
Animal Care and Use Committee (UOS IACUC; UOS-091201-
1).
Immunostaining and TUNEL assay
For immunohistochemistry, embryos were isolated and fixed in
4% paraformaldehyde overnight at RT, washed with 70%
ethanol, dehydrated, and embedded in paraffin. Sagittal embry-
onic sections (4 mm thick) were prepared using a microtome,
deparaffinized, rehydrated, and stained with anti-Ki-67 mouse
monoclonal antibody (1:20, BD Pharmingen) using Histomou-
se
TM-SP kit (Zymed) according to the manufacturer’s protocols
and visualized with a Zeiss Axio Imager microscope. For
immunofluorescence, embryos were isolated and fixed in cold
4% paraformaldehyde for 4 hours with gentle rocking, cryopro-
tected with 30% sucrose, and embedded in OCT freezing
medium. Thaw-mounted sagittal embryonic sections (7 mm thick)
were generated using a cryostat, permeabilized with 0.3% Triton
X-100/PBS, and blocked with 3% BSA/0.1% Triton X-100/PBS
for 1 hour at RT. Embryonic sections were incubated with anti-
phospho-histone 3 (PH3) rabbit polyclonal antibody (1:200,
Upstate) at 4uC overnight, washed with 0.1% Triton X-100/
PBS, and incubated with Alexa Fluor 555-conjugated goat anti-
rabbit IgG (1:200, Invitrogen) and TO-PRO-3 iodide (1:1,000,
Invitrogen) for 1 hour at RT. Sections were washed with 0.1%
Triton X-100/PBS, PBS only, and then mounted using the
ProLong Gold antifade reagent (Invitrogen). A confocal micro-
scope was used as described previously [15,16].
The TUNEL (terminal deoxynucleotidyl transferase dUTP nick
end labeling) assay was performed using an ApoptagH peroxidase
in situ apoptosis detection kit (Chemicon) for paraffin-embedded
sections, and an ApoptagH red in situ apoptosis detection kit
(Chemicon) for thaw-mounted frozen sections according to the
manufacturer’s protocols.
Cytospin of fetal liver cells
Fetal liver tissues were pulverized in PBS containing 1 mM
EDTA and 1% fetal bovine serum, treated with HBSS containing
1 mg/ml collagenase, 1 mg/ml hyaluronidase, and 12.5 mg/ml
DNase I for 30 min at 37uC, and medium containing 10% fetal
bovine serum was added before cytospin at 800 rpm for 5 min.
Equal numbers of fetal liver cells were used to attach on a cytospin
slide (20,000 cells/slide). Cells on cytospin slides were stained as
described previously with some modifications [13]. Briefly, cells
were fixed in 4% paraformaldehyde for 10 min at RT,
permeabilized with 0.2% Triton X-100/PBS, and blocked with
0.5% BSA/PBS for 30 min at RT. Fixed cells were incubated with
anti-CD45 rat monoclonal antibody (1:20, BD Pharmigen), anti-
E-cadherin mouse monoclonal antibody (1:20, BD Pharmigen),
anti-alpha-fetoprotein (AFP) rabbit polyclonal antibody (1:400,
Thermo Scientific), or anti-Ter119 rat monoclonal antibody
(1:500, BD Pharmigen) in combination with anti-Ki-67 mouse
monoclonal antibody (1:100, BD Pharmingen) or anti-phospho-
histone 3 (PH3) rabbit polyclonal antibody (1:100, Upstate) at 4uC
overnight, washed with PBS, and incubated with appropriate
Alexa Fluor 488 or 555-conjugated goat anti-mouse, rat, or rabbit
IgG (1:400, Invitrogen) for 1 hour at RT. Cells were mounted
using the ProLong Gold antifade reagent with DAPI (Invitrogen)
and visualized with a Zeiss Axio Imager microscope. To detect
apoptotic cells, the double-labeling fluorescence TUNEL assay
was performed using ApoptagH red in situ apoptosis detection kit
with appropriate markers according to the manufacturer’s
protocols.
Flow cytometric analysis of fetal liver cells
Fetal liver tissues were pulverized in PBS containing 1 mM
EDTA and 1% fetal bovine serum, and total liver cell number was
counted using a hematocytometer. Isolated fetal liver cells were
fixed in 4% paraformaldehyde, permeabilized with 90% metha-
nol, and stained with anti-CD45-APC antibody (1:200, BD
Pharmigen, pan-hematopoietic marker) and anti-Ter119-Cy7PE
antibody (1:1000, BD Pharmigen, erythroid cell marker). To
detect cells in proliferation, fetal liver cells were co-stained with
anti-Ki-67 antibody (1:50, BD Pharmingen), followed by Alexa
Fluor 488-conjugated anti-mouse IgG (1:400, Invitrogen). Isotype
control or secondary antibody was used to determine the range of
background fluorescence. Using FACSCanto II (BD Biosciences),
5610
4 events were collected and gated for CD45
+, Ter119
+,
CD45
2/Ter119
2 cells to obtain the frequency of specific cell
types.
Transplantation and HSC/progenitor reconstitution
analysis
Transplantation. Recipient mice (CD45.1) were lethally
irradiated with a dose of 800 rad and whole fetal liver cells from
donor (CD45.2) were obtained from E13.5 embryos. For non-
competitive transplantation, 1610
6 cells were transplanted by tail
vein within 6 hours of irradiation. For competitive transplantation,
1.5610
5 cells were transplanted by tail vein with 2610
5 recipient-
type whole bone marrow (BM) cells.
Reconstitution analysis. Reconstituted mice were
periodically bled via tail vein to monitor contribution by donor-
marked HSC/progenitors in the peripheral blood of B, T, and
myeloid lineages at 4, 8, 12, and 16 weeks post-transplant. Using a
heat lamp, the tail was heated and a sharp incision was made to
collect about 4–6 drops of blood in a tube containing 10 mM
EDTA/PBS. An equal volume of 2% dextran/PBS was added to
generate a density gradient and incubated at 37uC for 30 min to
precipitate red blood cells. The supernatant was collected and the
remaining red blood cells were lysed in buffer containing
ammonium chloride and potassium bicarbonate. Cells were then
stained with anti-CD45.1-PE antibody (to detect recipient cells),
was determined as described in Materials and Methods. All data in (A) and (B) are expressed as the means 6 SEM from the indicated number of
samples. In (C), open squares and circles represent data from an individual sample and closed squares and circles represent the means 6 SEM from
the indicated number of samples.
#P,0.1;
*P,0.05;
**P,0.01 vs. wild-type (Ubc
+/+) embryos.
doi:10.1371/journal.pone.0032956.g004
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Cy5PE antibody (erythroid cell marker), anti-B220-Cy7APC
antibody (B lymphocyte marker), anti-CD3-APC antibody (T
lymphocyte marker), and anti-Mac1-Cy7PE antibody (myeloid cell
marker). Using LSR II (BD Biosciences), 1610
6 events were
collected and Ter119
2 cells (also PI
2 for live cells) were gated for
donor cells (CD45.2
+) and analyzed for B cells (B220
+) vs. myeloid
cells (Mac1
+, including Mac1
high and Mac1
low) in donor cell
populations. B220
2 and Mac1
2 populations were further
analyzed for T cells (CD3
+). As reported previously, T cells were
hardly present in donor cell populations at 4 weeks post-transplant
[24].
Donor-marked granulocyte frequency was expressed as % of
white blood cells (WBC) at 4-week intervals after transplantation
into recipient mice. Donor granulocyte chimerism was determined
by analyzing the percentage of Ter119
2CD3
2B220
2Mac1
highside
scatter
high cells that were also donor
+.
Indirect competitive ELISA and quantitative real-time RT-
PCR
Indirect competitive ELISA and quantitative real-time RT-
PCR were carried out as described previously [13,15].
Statistical analysis
Two-tailed unpaired Student’s t-tests were used to compare the
data between two groups. Although P,0.05 was considered to be
statistically significant in most cases, P,0.1 was also noted in
certain cases.
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